Announcements

MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

• Biology and Life Sciences;
• Business and Economics;
• Chemistry and Materials Sciences;
• Computer Sciences and Mathematics;
• Engineering;
• Environmental and Earth Sciences;
• Medicine and Pharmacology;
• Social Sciences, Arts and Humanities;
• Physical Sciences;
• Public Health and Healthcare.

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

Engineering is a cornerstone of modern scientific and technological progress, translating fundamental discoveries into practical solutions for global challenges in energy, climate, infrastructure, manufacturing, healthcare, transportation, digitalization, and geological resource development. Driven by rapid advances in digitalization, intelligence, sustainability, materials innovation, and cross‑disciplinary integration, the “Engineering” Section of Sci (ISSN: 2413-4155) serves as a high‑visibility platform for rigorous research bridging engineering science, technological innovation, and real‑world implementation.

Its mission is to connect foundational knowledge with industrial and societal impact, welcoming theoretical modeling, simulation, experimentation, prototype design, system integration, and large‑scale applications. The Section prioritizes sustainable, scalable solutions, mechanism–structure–function–performance relationships, and interdisciplinary collaboration across engineering, materials science, geology, computer science, physics, chemistry, biology, and environmental science.

This Section covers, but is not limited to, the following thematic areas:

1. Sustainable and Energy Engineering
   • Renewable energy systems (solar, wind, hydro, geothermal, biomass);
   • Energy storage, conversion, and smart grid technologies;
   • Carbon capture, utilization, and storage (CCUS);
   • Energy efficiency, waste heat recovery, and industrial decarbonization;
   • Hydrogen production, storage, and utilization;
   • Circular economy and life‑cycle engineering.

2. Materials Science and Engineering
   • Structural, functional, and advanced engineering materials;
   • Metallic, ceramic, polymer, composite, and hybrid materials;
   • Nanomaterials, biomaterials, and smart/intelligent materials;
   • Materials synthesis, processing, and manufacturing technologies;
   • Materials characterization, microstructure, and properties;
   • Materials failure analysis, fatigue, corrosion, and durability;
   • Sustainable and recyclable materials development;
   • High‑temperature, extreme‑environment materials.

3. Civil and Infrastructure Engineering
   • Sustainable construction materials and low‑carbon building technologies;
   • Smart cities, intelligent infrastructure, and resilient transportation systems;
   • Bridge, tunnel, and underground engineering;
   • Green building and net‑zero infrastructure;
   • Infrastructure durability, monitoring, and rehabilitation.

4. Geological and Geotechnical Engineering
   • Geotechnical engineering and soil‑rock mechanics;
   • Engineering geology, geological hazard assessment and mitigation;
   • Landslide, debris flow, earthquake, and disaster engineering;
   • Ground improvement, foundation engineering, and deep excavation;
   • Tunnel and underground space engineering in complex geology;
   • Geological resource exploration, mining engineering, and mine reclamation;
   • Geothermal development and geological carbon storage;
   • Hydrogeology and engineering groundwater control.

5. Mechanical and Manufacturing Engineering
   • Advanced machining, forming, and near‑net‑shape manufacturing;
   • Additive manufacturing (3D printing) of metals, ceramics, and composites;
   • Intelligent manufacturing, digital twins, and industrial IoT;
   • Robotics, automation, and mechatronics;
   • Tribology, surface engineering, and high‑performance machinery;
   • Reliability, fault diagnosis, and predictive maintenance.

6. Electrical, Electronic and Power Engineering
   • Power electronics, converters, inverters, and motor drives;
   • Wide‑bandgap semiconductor devices and applications;
   • Electric vehicle (EV) powertrains and charging infrastructure;
   • High‑voltage engineering, insulation, and pulsed power;
   • Electromagnetic compatibility (EMC) and antenna engineering;
   • Renewable energy grid integration and stability control.

7. Chemical and Process Engineering
   • Advanced reaction engineering, separation, and purification technologies;
   • Green chemistry, sustainable processes, and solvent engineering;
   • Biochemical engineering, biorefineries, and bioprocessing;
   • Polymer processing, functional coatings, and membrane technology;
   • Industrial catalysis, process intensification, and optimization.

8. Environmental and Ecological Engineering
   • Pollution control (air, water, soil, solid waste);
   • Environmental remediation and ecological restoration;
   • Sustainable waste management and recycling technologies;
   • Environmental monitoring, sensing, and risk assessment;
   • Eco‑industrial systems and low‑carbon process engineering.

9. Biomedical and Healthcare Engineering
   • Biomedical devices, implants, and wearable bioelectronics;
   • Medical imaging, sensing, and diagnostic instruments;
   • Tissue engineering, regenerative medicine, and drug delivery systems;
   • Rehabilitation engineering, assistive robotics, and smart healthcare;
   • Biomechanics, human–machine interaction, and medical AI.

10. Aerospace, Marine and Transportation Engineering
    • Aerospace materials, structures, propulsion, and avionics;
    • Marine engineering, offshore structures, and underwater systems;
    • Intelligent and connected vehicles, autonomous navigation;
    • High‑speed transportation and new‑concept mobility systems;
    • Satellite engineering, remote sensing, and aerospace IoT.

11. AI and Digital Engineering
    • Machine learning and data‑driven engineering design;
    • Engineering informatics, high‑throughput computation, and optimization;
    • Digital twins, simulation‑driven development, and virtual engineering;
    • Intelligent sensing, edge computing, and cyber–physical systems;
    • AI for predictive maintenance, quality control, and autonomous systems.

12. Agricultural Engineering
    • Agricultural mechanization and intelligent equipment;
    • Precision agriculture, smart farming, and digital agriculture technologies;
    • Crop production engineering, soil and water conservation engineering;
    • Irrigation and drainage engineering; water-saving agriculture;
    • Post-harvest technology, processing, and storage of agricultural products;
    • Livestock and aquaculture engineering, animal housing, and environmental control;
    • Agricultural waste utilization and biorefinery engineering;
    • Rural energy engineering and agricultural carbon neutrality.

13. Industrial Engineering
    • Operations research, optimization, and system modeling;
    • Production planning, scheduling, and supply chain management;
    • Lean manufacturing, Six Sigma, and quality engineering;
    • Work study, ergonomics, and human factors engineering;
    • Industrial automation, robotics, and intelligent manufacturing;
    • Logistics engineering, warehouse design, and distribution systems;
    • Cost engineering, productivity improvement, and industrial management;
    • Sustainable industrial systems and green manufacturing.

14. Ocean Engineering
    • Coastal and offshore structural engineering;
    • Offshore oil and gas engineering, subsea engineering systems;
    • Ocean renewable energy (wave, tidal, offshore wind);
    • Ocean environmental engineering and marine pollution control;
    • Port and harbor engineering; coastal protection and restoration;
    • Underwater acoustics, marine surveying, and ocean observation;
    • Deep-sea engineering and marine resource development.

15. Interdisciplinary and Emerging Engineering
    • Micro/nano engineering and lab‑on‑a‑chip systems;
    • Flexible electronics, soft robotics, and intelligent materials;
    • Integrated engineering systems for energy–water–food–geology nexus;
    • Multi‑disciplinary design optimization and systems engineering;
    • Novel engineering theories, methodologies, and frontier technologies.

Clinical medicine and healthcare are central to advancing global health, disease prevention, diagnosis, treatment, and quality of life. Driven by innovations in medical technology, digital health, precision medicine, translational research, and interdisciplinary integration, modern clinical practice is evolving toward personalized, predictive, preventive, and participatory care. The “Clinical Medicine and Healthcare” Section of Sci (ISSN: 2413-4155) offers a high‑visibility platform for rigorous research bridging basic medical science, translational investigation, clinical practice, and public health implementation.

Its mission is to translate scientific insights into improved patient outcomes, healthcare efficiency, and population health. The Section welcomes original research, clinical trials, observational studies, systematic reviews, and methodological advances across all clinical disciplines, with emphasis on evidence‑based medicine, precision diagnostics, targeted therapeutics, patient safety, health equity, digital transformation, and cross‑disciplinary collaboration.

This Section covers, but is not limited to, the following thematic areas:

1. Internal Medicine and Subspecialties
   • Cardiology, gastroenterology, nephrology, neurology, pulmonology;
   • Endocrinology, rheumatology, hematology, infectious diseases;
   • Geriatrics, general internal medicine, chronic disease management;
   • Precision internal medicine, personalized risk stratification;

2. Surgery and Surgical Specialties
   • General surgery, orthopedic surgery, neurosurgery;
   • Cardiothoracic surgery, urology, obstetric and gynecologic surgery;
   • Otolaryngology, ophthalmic surgery, plastic and reconstructive surgery;
   • Minimally invasive surgery, robotic surgery, surgical oncology;
   • Perioperative care, surgical safety, rehabilitation surgery.

3. Oncology and Cancer Medicine
   • Clinical oncology, medical oncology, radiation oncology;
   • Cancer screening, early diagnosis, prognostic biomarkers;
   • Targeted therapy, immunotherapy, personalized cancer treatment;
   • Palliative care, survivorship, supportive oncology;
   • Cancer epidemiology and prevention strategies.

4. Pediatrics and Neonatology
   • Pediatric general medicine and subspecialties;
   • Neonatal intensive care, perinatal medicine;
   • Growth and development, pediatric nutrition;
   • Congenital disorders, pediatric infectious diseases;
   • Adolescent medicine and pediatric public health.

5. Obstetrics and Gynecology
   • Reproductive medicine, fertility, assisted reproductive technology;
   • Pregnancy care, high‑risk obstetrics, maternal‑fetal medicine;
   • Gynecologic oncology, endocrinology, urogynecology;
   • Menopausal health, family planning, women’s health equity.

6. Neurology and Neurosciences
   • Clinical neurology, neurorehabilitation;
   • Stroke, epilepsy, neurodegenerative diseases;
   • Neurocritical care, sleep medicine, pain management;
   • Neuroimaging, neuromodulation, neuroprosthetics.

7. Psychiatry and Mental Health
   • Clinical psychiatry, psychological medicine;
   • Depression, anxiety, schizophrenia, bipolar disorder;
   • Addiction medicine, trauma‑informed care;
   • Child and adolescent psychiatry, geriatric psychiatry;
   • Digital mental health, psychotherapy outcomes research.

8. Emergency and Critical Care Medicine
   • Emergency medicine, trauma care, resuscitation science;
   • Critical care medicine, intensive care unit (ICU) management;
   • Sepsis, multi‑organ failure, life support technologies;
   • Point‑of‑care diagnostics, emergency public health.

9. Diagnostic and Laboratory Medicine
   • Clinical pathology, anatomical pathology;
   • Laboratory medicine, clinical biochemistry, microbiology;
   • Molecular diagnostics, genomics, liquid biopsy;
   • Imaging diagnostics (radiology, ultrasound, MRI, CT);
   • Pathogen detection, biomarker validation.

10. Pharmacy and Clinical Pharmacology
    • Clinical pharmacy, pharmacotherapy optimization;
    • Pharmacogenomics, personalized drug dosing;
    • Drug safety, pharmacovigilance, adverse drug reactions;
    • Antimicrobial stewardship, rational drug use;
    • Novel drug delivery systems and clinical translation.

11. Dentistry and Oral Health
    • Oral medicine, oral and maxillofacial surgery;
    • Preventive dentistry, restorative dentistry;
    • Orthodontics, pediatric dentistry, periodontology;
    • Oral oncology, dental materials, oral public health.

12. Public Health and Preventive Medicine
    • Epidemiology, biostatistics, health services research;
    • Health policy, healthcare systems, health economics;
    • Disease prevention, health promotion, vaccination;
    • Global health, health equity, environmental health;
    • Occupational health, travel medicine, disaster health.

13. Nursing and Allied Health Professions
    • Clinical nursing, specialized nursing care;
    • Nursing education, evidence‑based nursing practice;
    • Physiotherapy, occupational therapy, rehabilitation;
    • Nutrition and dietetics, speech therapy;
    • Allied health innovation and interprofessional care.

14. Digital Health and Medical Technology
    • Telemedicine, telehealth, remote patient monitoring;
    • Artificial intelligence in clinical medicine and diagnostics;
    • Wearable sensors, mobile health (mHealth), big data analytics;
    • Electronic health records, health informatics, cybersecurity;
    • Medical devices, point‑of‑care technologies, digital therapeutics.

15. Translational and Precision Medicine
    • Translational research from bench to bedside;
    • Genomics, proteomics, metabolomics in clinical care;
    • Predictive modeling, risk stratification, personalized prevention;
    • Regenerative medicine, cell therapy, gene therapy clinical trials;
    • Implementation science in healthcare.

16. Patient Safety and Quality Improvement
    • Healthcare quality assurance, accreditation;
    • Patient safety, error reduction, root‑cause analysis;
    • Clinical guidelines, standardized care pathways;
    • Patient‑centered care, shared decision‑making;
    • Healthcare equity and accessibility.

17. Geriatrics and Long‑Term Care
    • Geriatric syndromes, frailty, multimorbidity;
    • Long‑term care, palliative and end‑of‑life care;
    • Geriatric pharmacology, cognitive disorders;
    • Home care, rehabilitation, aging in place.

18. Infectious Diseases and Global Health
    • Clinical infectious diseases, antimicrobial resistance;
    • Viral infections, bacterial infections, fungal diseases;
    • Pandemic preparedness, surveillance, containment;
    • Travel and tropical medicine, zoonotic diseases;
    • Global infectious disease control and elimination.

19. Allergy, Immunology and Autoimmunity
    • Clinical allergy, asthma, anaphylaxis;
    • Primary immunodeficiencies, autoimmune diseases;
    • Immunotherapy, desensitization, immune regulation;
    • Transplant immunology, graft‑versus‑host disease.

We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.

A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.

Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.

To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.

A Conversation with the Chair

1. Could you please introduce yourself and your research journey?

My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.

I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.

Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.

2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?

Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.

3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?

A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.

4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?

Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.

5. What do you see as the key challenges or opportunities currently facing the field?

We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.

6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?

The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.

7. What message would you like to convey to the research community and the public during this open nomination phase?

This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.

About the Tu Youyou Award

Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.

The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

Conference: The 4th Global Conference of Innovation Materials & MRS-K Spring Meeting (GCIM 2026)
Date: 31 May–4 June 2026
Location: ICC Jeju, Jeju Island, Republic of Korea

The 4th Global Conference of Innovation Materials & MRS-K Spring Meeting (GCIM 2026) aims to serve as a premier platform for fostering international exchange in the field of advanced materials science. The conference focuses on bridging the gap between fundamental research and industrial application, showcasing breakthroughs in sustainable, functional, and smart materials.

By bringing together leading scientists, engineers, and industry experts, GCIM 2026 is anticipated to be a forum for exploring the next generation of materials that will drive global innovation and address complex environmental challenges.

MDPI will be attending the 4th Global Conference of Innovation Materials & MRS-K Spring Meeting as an exhibitor. The event will take place from 31 May to 4 June 2026. We invite all attendees to visit our booth to explore potential collaborations, share professional insights, and discuss your latest research findings with us.

The following MDPI journals will be represented at the conference:

• Materials;
• Sci;
• Crystals;
• Electronics;
• Fibers;
• Gels;
• Micro;
• Nanoenergy Advances;
• Physchem;
• Surfaces.

Our team is excited to welcome you to our booth for a face-to-face discussion and to assist with any of your inquiries. For more information regarding this conference, please visit the following website: https://gcim2026.org/index.php.

Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.

Prize

– CHF 100,000;
– A medal;
– A certificate.

The monetary prize will be shared equally should there be multiple recipients.

Who May Be Nominated?

– Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle.

Who May Submit a Nomination?

– The director of the nominee’s host research institution or recognized scientists within the field.

Self-nominations will not be considered.

Nomination Materials

– A biographical sketch;
– A detailed description of the nominee’s contributions;
– 5–10 representative academic publications;
– A list of academic honors, awards, and funded projects;
– A nomination letter signed by two nominators.

How to Submit?

Submit nominations online via the following link: https://tuyouyouprize.org/nomination

Important Dates

– Nomination Deadline: 31 October 2026
– Winner Announcement: March 2027

For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/). For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

To further enhance the quality of Sci (ISSN: 2413-4155) and the papers published in it, under the guidance of the Editor-in-Chief (Prof. Dr. Claus Jacob) and four Section Editors-in-Chief (Prof. Dr. Atanas G. Atanasov, Prof. Dr. Alexandru Mihai Grumezescu, Prof. Dr. Jose Navarro Pedreño and Prof. Dr. Nik Bessis), the journal has updated and revised its Sections’ Information. The original Sections’ Information and the updated versions are listed below:

To further enhance the quality of Sci and the papers published in it, under the guidance of editor-in-chief Prof. Dr. Claus Jacob, the journal has updated and revised its aims. The original aims and the updated version are listed below: